Medline, Inc. Stock-Based Comp increased by 21.1% to $23.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.1%, from $19.00M to $23.00M.
An increase may signal a strategy to preserve cash or align employee interests with shareholders, but it also results in share dilution.
Stock-based compensation is a non-cash expense where employees and executives are rewarded with equity or stock options...
High-growth technology firms often have higher stock-based compensation as a percentage of revenue compared to mature industrial firms.
stock_based_compensation| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.50M | $19.50M | $19.50M | $19.50M | $15.25M | $15.25M | $15.25M | $15.25M | $19.00M | $23.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -21.8% | +0.0% | +0.0% | +0.0% | +24.6% | +21.1% |
| YoY Change | — | — | — | — | -21.8% | -21.8% | -21.8% | -21.8% | +24.6% | +21.1% |